Whole Blood Gene Expression Profiles to Assess Pathogenesis and Disease Severity in Infants with Respiratory Syncytial Virus Infection

English version České info

Background:
Respiratory syncytial virus (RSV) is the leading cause of viral lower respiratory tract infection (LRTI) and hospitalization in infants. Mostly because of the incomplete understanding of the disease pathogenesis, there is no licensed vaccine, and treatment remains symptomatic. We analyzed whole blood transcriptional profiles to characterize the global host immune response to acute RSV LRTI in infants, to characterize its specificity compared with influenza and human rhinovirus (HRV) LRTI, and to identify biomarkers that can objectively assess RSV disease severity.

Methods and Findings:
This was a prospective observational study over six respiratory seasons including a cohort of infants hospitalized with RSV (n = 135), HRV (n = 30), and influenza (n = 16) LRTI, and healthy age- and sex-matched controls (n = 39). A specific RSV transcriptional profile was identified in whole blood (training cohort, n = 45 infants; Dallas, Texas, US) and validated in three different cohorts (test cohort, n = 46, Dallas, Texas, US; validation cohort A, n = 16, Turku, Finland; validation cohort B, n = 28, Columbus, Ohio, US) with high sensitivity (94% [95% CI 87%–98%]) and specificity (98% [95% CI 88%–99%]). It classified infants with RSV LRTI versus HRV or influenza LRTI with 95% accuracy. The immune dysregulation induced by RSV (overexpression of neutrophil, inflammation, and interferon genes, and suppression of T and B cell genes) persisted beyond the acute disease, and immune dysregulation was greatly impaired in younger infants (<6 mo). We identified a genomic score that significantly correlated with outcomes of care including a clinical disease severity score and, more importantly, length of hospitalization and duration of supplemental O₂.

Conclusions:
Blood RNA profiles of infants with RSV LRTI allow specific diagnosis, better understanding of disease pathogenesis, and assessment of disease severity. This study opens new avenues for biomarker discovery and identification of potential therapeutic or preventive targets, and demonstrates that large microarray datasets can be translated into a biologically meaningful context and applied to the clinical setting.

Please see later in the article for the Editors' Summary

Vyšlo v časopise: Whole Blood Gene Expression Profiles to Assess Pathogenesis and Disease Severity in Infants with Respiratory Syncytial Virus Infection. PLoS Med 10(11): e32767. doi:10.1371/journal.pmed.1001549
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001549

Souhrn

Zdroje

1. BryceJ, Boschi-PintoC, ShibuyaK, BlackRE (2005) WHO estimates of the causes of death in children. Lancet 365: 1147–1152.

2. MulhollandK, HiltonS, AdegbolaR, UsenS, OparaugoA, et al. (1997) Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. Lancet 349: 1191–1197.

3. KlugmanKP, MadhiSA, HuebnerRE, KohbergerR, MbelleN, et al. (2003) A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349: 1341–1348.

4. MadhiSA, KlugmanKP (2004) A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 10: 811–813.

5. BerkleyJA, MunywokiP, NgamaM, KazunguS, AbwaoJ, et al. (2010) Viral etiology of severe pneumonia among Kenyan infants and children. JAMA 303: 2051–2057.

6. HallCB, WeinbergGA, IwaneMK, BlumkinAK, EdwardsKM, et al. (2009) The burden of respiratory syncytial virus infection in young children. N Engl J Med 360: 588–598.

7. NairH, NokesDJ, GessnerBD, DheraniM, MadhiSA, et al. (2010) Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375: 1545–1555.

8. GarciaCG, BhoreR, Soriano-FallasA, TrostM, ChasonR, et al. (2010) Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics 126: e1453–e1460.

9. NolteFS, MarshallDJ, RasberryC, SchievelbeinS, BanksGG, et al. (2007) MultiCode-PLx system for multiplexed detection of seventeen respiratory viruses. J Clin Microbiol 45: 2779–2786.

10. GarciaC, Soriano-FallasA, LozanoJ, LeosN, GomezAM, et al. (2012) Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis. Pediatr Infect Dis J 31: 86–89.

11. MellaC, Suarez-ArrabalMC, LopezS, StephensJ, FernandezS, et al. (2013) Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis 207: 564–573.

12. TalA, BavilskiC, YohaiD, BearmanJE, GorodischerR, et al. (1983) Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics 71: 13–18.

13. BerryMP, GrahamCM, McNabFW, XuZ, BlochSA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973–977.

14. BanchereauR, Jordan-VillegasA, ArduraM, MejiasA, BaldwinN, et al. (2012) Host immune transcriptional profiles reflect the variability in clinical disease manifestations in patients with Staphylococcus aureus infections. PLoS ONE 7: e34390 doi:10.1371/journal.pone.0034390

15. RamiloO, AllmanW, ChungW, MejiasA, ArduraM, et al. (2007) Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109: 2066–2077.

16. AllantazF, ChaussabelD, StichwehD, BennettL, AllmanW, et al. (2007) Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. J Exp Med 204: 2131–2144.

17. BenjaminiY, HochbergY (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57: 289–300.

18. WittkowskiKM, SongT (2010) Nonparametric methods for molecular biology. Methods Mol Biol 620: 105–153.

19. WittkowskiKM, LeeE, NussbaumR, ChamianFN, KruegerJG (2004) Combining several ordinal measures in clinical studies. Stat Med 23: 1579–1592.

20. ArduraMI, BanchereauR, MejiasA, Di PucchioT, GlaserC, et al. (2009) Enhanced monocyte response and decreased central memory T cells in children with invasive Staphylococcus aureus infections. PLoS ONE 4: e5446 doi:10.1371/journal.pone.0005446

21. ChaussabelD, QuinnC, ShenJ, PatelP, GlaserC, et al. (2008) A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29: 150–164.

22. ObermoserG, PresnellS, DomicoK, XuH, WangY, et al. (2013) Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 38: 831–844.

23. PanklaR, BuddhisaS, BerryM, BlankenshipDM, BancroftGJ, et al. (2009) Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol 10: R127.

24. ShiL, CampbellG, JonesWD, CampagneF, WenZ, et al. (2010) The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol 28: 827–838.

25. HuangYC, LiZ, HyseniX, SchmittM, DevlinRB, et al. (2008) Identification of gene biomarkers for respiratory syncytial virus infection in a bronchial epithelial cell line. Genomic Med 2: 113–125.

26. MartinezI, LombardiaL, Garcia-BarrenoB, DominguezO, MeleroJA (2007) Distinct gene subsets are induced at different time points after human respiratory syncytial virus infection of A549 cells. J Gen Virol 88: 570–581.

27. IoannidisI, McNallyB, WilletteM, PeeplesME, ChaussabelD, et al. (2012) Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection. J Virol 86: 5422–5436.

28. BhojVG, SunQ, BhojEJ, SomersC, ChenX, et al. (2008) MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus. Proc Natl Acad Sci U S A 105: 14046–14051.

29. JanssenR, PenningsJ, HodemaekersH, BuismanA, van OostenM, et al. (2007) Host transcription profiles upon primary respiratory syncytial virus infection. J Virol 81: 5958–5967.

30. PenningsJL, SchuurhofA, HodemaekersHM, BuismanA, de RondLC, et al. (2011) Systemic signature of the lung response to respiratory syncytial virus infection. PLoS ONE 6: e21461 doi:10.1371/journal.pone.0021461

31. FjaerliHO, BukholmG, SkjaeretC, HoldenM, NakstadB (2007) Cord blood gene expression in infants hospitalized with respiratory syncytial virus bronchiolitis. J Infect Dis 196: 394–404.

32. FjaerliHO, BukholmG, KrogA, SkjaeretC, HoldenM, et al. (2006) Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis. BMC Infect Dis 6: 175.

33. BucasasKL, MianAI, Demmler-HarrisonGJ, CavinessAC, PiedraPA, et al. (2013) Global gene expression profiling in infants with acute respiratory syncytial virus broncholitis demonstrates systemic activation of interferon signaling networks. Pediatr Infect Dis J 32: e68–e76.

34. SmithSB, DampierW, TozerenA, BrownJR, Magid-SlavM (2012) Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysis. PLoS ONE 7: e33174 doi:10.1371/journal.pone.0033174

35. ZaasAK, ChenM, VarkeyJ, VeldmanT, HeroAO3rd, et al. (2009) Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 6: 207–217.

36. GarofaloRP, HintzKH, HillV, PattiJ, OgraPL, et al. (2005) A comparison of epidemiologic and immunologic features of bronchiolitis caused by influenza virus and respiratory syncytial virus. J Med Virol 75: 282–289.

37. GillMA, LongK, KwonT, MunizL, MejiasA, et al. (2008) Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection. J Infect Dis 198: 1667–1676.

38. WelliverTP, GarofaloRP, HosakoteY, HintzKH, AvendanoL, et al. (2007) Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 195: 1126–1136.